1. ’t Hoen EFM (2009) The global politics of pharmaceutical monopoly power: drug patents, access, innovation and the application of WTO declaration on TRIPS and public health. AMB, Amsterdam
2. Abbott FM (2005) Toward a new era of objective assessment in the field of TRIPS and variable geometry for the preservation of multilateralism. J Int Econ Law 8:77
3. Abbott FM, Reichman JH (2007) Access to essential medicines: lessons learned since the Doha declaration on the TRIPS agreement and public health, and policy options for the European Union. Report to the Directorate-General/External Policies for the European Union
4. Adusei P (2010) Regulatory diversity as key to the ‘Myth’ of drug patenting in Sub-Saharan Africa. J Afr Law 54:26
5. Amani B (2009) State agency and the patenting of life in international law: merchants and missionaries in a global society. Ashgate, Surrey